devices to repair fractured hips, regulate heart rate, replace arteries and veins, and dialyse blood have all come into widespread use. We have learned how to transplant kidneys, livers and bone marrow, how to avoid graft rejection and how to suppress graft vs. host reactions [Murray 1992) . We have learned how to stop the heart, divert and oxygenate the blood, clear thombosed coronary arteries, replace valves, correct faulty conduction pathways, repair congenital anomalies and then start the heart back up. Today more than 200 000 people benefit from heart surgery in the USA annually. In many instances coronary artery disease can be treated by the application of clot-dissolving enzymes via catheterization or by the systemic administration of tissue plasminogen activator. It has been estimated that the combined effects of drugs and surgery used in the treatment of coronary heart disease saved 671 000 lives between 1968-1986 in the US alone (Massachusetts Society for Medical Research 1992) . Additionally, it has been Laboratory Animals (1994) 28,158-171 estimated that between 2.6-6 million nonfatal strokes and 456000 deaths were avoided due to implementation of measures to control hypertension (Massachusetts Society for Medical Research 1992) . But perhaps our greatest accomplishment has been the world-wide eradication of smallpox based on the principles of vaccination.
These are but a few of the medical advances we have seen brought into common use during the past 25 years and each of them were dependent on animal research (Hughes 1990 , National Academy of Science 1991 . In fact, between 1901-198254 of the 76 Nobel Prizes in Medicine and Physiology were awarded to individuals whose discoveries involved the use of animals (Leader &. Stark 1987) .
Parallel to the advances occurring in the life sciences are the extraordinary advances in laboratory animal science. I was introduced to the field of laboratory animal medicine in 1967 as a veterinary student.
During that year I received the first formal course in this new field taught at the University of Pennsylvania. The next year I enrolled in a research elective in transplantation biology, under the mentorship of Dr Charles Schaffer and Dr Rupert Billingham. The field of immunology was rapidly developing and the mysteries of T and B cell cooperation were just unfolding. Investigators were attempting to elucidate the genetic basis of graft rejection and the molecular basis for antibody-antigen binding. It was very exciting. However, I also remember the high mortality due to infectious diseases in our laboratory rats and mice. I remember the difficulty of developing a congenic line of rats while trying to battle chronic murine mycoplasmosis and the difficulty interpreting scientific data collected in mice experiencing epizootics of Sendai virus infection. The changes that have occurred in laboratory animal science since this time required a multidisciplinary effort using basic science principles gathered in the fields of gnotobiotics, nutrition, biochemistry, physiology, genetics, immunology and engineering. These 159 changes are reflected today in the numbers and types of animals we use, the articles we write and the research we conduct using those animals.
I would like to begin by investigating briefly:
1. our concerns in laboratory animal science in 1967 and 1991 by examining the subjects of articles published during those years, 2. changes in the pattern of animal use in the US and UK, and 3. changes in legislation designed to improve standards of animal use world-wide.
Our concerns
The per cent by category of articles published in Laboratory Animals in 1967 indicates that laboratory animal diseases (38%) were our major concern, followed by zoonoses and occupational health and safety issues (23%), articles on breeding (15%), facility design (11% 1, management (5%), behaviour 14%), and genetics 14%). By 1991 laboratory animal diseases ranked first (31%), animal models of human disease ranked second (19%), followed by research techniques (19%), normative biology and behaviour (11%), genetics (7%), nutrition (7%) and anaesthesia [6%). While it may not be fair to make these comparisons because the total number of articles in 1991 was much larger, it is sufficient to show trends and the nature of our interests. Examination of the laboratory animal literature in the US during the same period shows a similar trend. Spontaneous disease of laboratory animals is still the primary focus of published papers. However, it is clear that the nature of these investigations is different. While characterization of new diseases is as important today as it was 25 years ago-the application of new techniques to examine the cellular and molecular basis of disease have given us a new understanding of disease pathogenesis. Factors such as the host response to infection and molecular mechanisms for evading host defences are important to us because they have direct implications for colony management. However, they are important to others in comparative medicine because they deal with the nature of disease pathogenesis and have direct applications for future therapy and vaccine development. DNA hybridization techniques including polymerase chain reaction are being employed as diagnostic tools resulting in increased sensitivity and specificity. While we continue to be concerned about laboratory safety (especially zoonoses) as well as the design and operation of animal facilities, the description and characterization of animal diseases with similarities to human disorders now comprises a significant part of our journals. In many instances laboratory animal veterinarians and those concerned with laboratory animal science are participating in the characterization of new animal models.
Patterns of animal use
The numbers and types of animals we use have also changed over the past 25 years.
Total numbers of animal experiments in the UK appears to have plateaued in the 1970s according to one survey [Paton 1984J . Various estimates of total vertebrate animal use have been made in the US and while exact figures are not presently available, except for species covered by the United States Department of Agriculture (USDA), most people accept the various national surveys as being close approximations. According to these figures, the number of vertebrate animals used in research, teaching and testing appears to have peaked in the early 1970s.
While various reasons have been given to explain the apparent decline in total numbers of animals used in the 1970s and early 1980s, I personally feel improvements in laboratory animal science have played a major role. In addition, public concern for the manner in which we use animals has had a long history in each of our countries, being manifested by national legislation as early as 1876 in the UK and 1966 in the US. However, during the past twenty Quimby years, dramatic changes in public sentiment have occurred resulting in new national laws being enacted in both countries. It is clear that many advances in laboratory animal medicine were driven by these legislative mandates.
Protective legislation
Prior to 1960, Canada had enacted a Criminal Code, a section of which specifically forbade cruelty to animals including those used in research. A voluntary control programme specifically dealing with research animals was recommended by the Special Committee on the Care of Experimental Animals (1966) . As a result the Canadian Council on Animal Care (CCAC) was established in 1968 as a standing committee of the Association of Universities and Colleges of Canada with the mission of developing guiding principles for the care of experimental animals and providing a programme for their effective application. This programme included the establishment of local Institutional Animal Care Committees which reviewed the proposed use of vertebrate animals. While the CCAC recommendations were not legally binding, compliance was required to secure funding from two major national agencies: the Medical Research Council and the Natural Science and Engineering Research Council. Proventiallaws directed at specific research animal activities were later passed in Ontario, Saskatchewan and Alberta.
In the US, congressional hearings on research animal use began in the early 1960s with the eventual passage of the Animal Welfare Act in 1966. This Act was amended in 1970, 1976 and 1985 with the 1985 amendment requiring a total revision of all previous standards. The 1985 amendment called for Institutional Animal Care and Use Committees [IACUC) to review and approve (or disapprove) of all proposed vertebrate animal use. That review must include considerations for species used, numbers, procedures and qualifications of investigators. Every institution using animals must be registered and their veterinary care programmes examined. Also, in 1985 Congress enacted the Health Research Extension Act with a major component dealing with Improved Laboratory Animal Standards. This act covered all vertebrate animals, required IACUC approval of proposed use and established the PHS as the enforcement agency. While compliance with this Act was initially required only for PHS awardee institutions now virtually all federal and most major private foundations require compliance as a condition for funding. In 1992 the US Congress passed the first Act which specifically protects research institutions and farmers from individuals who seek to disrupt activities involving animals.
Individual states in the US have also enacted research animal protective legislation; currently 20 states have such laws. Some states, such as NY, require institutional review committees (since 1983) and maintain veterinary officials to enforce the Act. At least one city in the US (Cambridge, MA) has enacted municipal legislation to protect research animals. The ability of research facilities to acquire unwanted dogs and cats from shelters (known as pound seizure) was once widespread, however, many states have repealed their pound seizure laws and 13 states now prohibit the use of pound animals in research. Most recently, as a result of increased violence at research institutions, 30 states have enacted protective legislation for those conducting research. As you can see, there has been heightened public interest and legislative activity at all levels of government in North America. Most of this activity has occurred during the past 25 years.
But North America was not alone, countries throughout Europe, Australia and Japan have all enacted legislation to protect research animals. In the UK where protective legislation was enacted in 1876, new legislative activity appeared in the 1980s: culminating in the 1986 Animals (Scientific Procedures) Act.
In 1986 the Council of Europe issued an agreement entitled: (the) European Convention for the protection of vertebrate 161 animals used for experimental and other scientific purposes. While signed by 14 member states, it has only been ratified by six. Also in 1986 the Council of European Communities adopted Directive 86/609/ EEC. This Directive contained provisions similar to the Convention, however, these provisions were binding for all member states. The Directive endeavours to harmonize legislation among members and to ensure that animals used for experimental and other scientific purposes are handled humanely, that pain is minimized and that the numbers used are reduced to a minimum.
In addition, various portions of Australia and the country of Japan enacted legislation during the past 25 years. It is clear that throughout the world there is a new level of public interest in what we do with animals. This public awareness has resulted from announcements of increasing numbers of medical advances requiring animal experimentation, the increased fear that companion animals may be stolen and used in experimentation, the increased efforts by animal welfare institutions to improved standards in research, and the uncommon but widely publicized instances where humane animal care standards had been compromised. With these broad concepts as background, I would now like to discuss events in laboratory animal science that paralleled these activities and may, in part, have led to the changes seen.
Dealing with infectious diseases in laboratory animals
In the first volume of Laboratory Animals an article written by John Seamer and F. C. Chesterman included the results of a survey on the prevalence of laboratory animal disease during 1964 in 40 institutions within the UK (Seamer & Chesterman 1967) . The results suggested that infectious diseases of laboratory mice and rats were quite prevalent with up to 75% of institutions reporting respiratory disease in rats. Reports published in the US during the same period indicated that infection of laboratory rodents with Salmonella sp (Margard et al. 1963) , Mycoplasma pulmonis (Nelson 1963) and helminths (King & Cosgrove 1963) were common.
Demand for rodents in the 1950s and early 1960s was great, high quality space for housing was precious and our knowledge of disease pathogenesis, treatment and control was rudimentary. But this last factor was soon to change as investigators on both sides of the Atlantic began characterizing the many pathogenic agents infecting our colonies. Between 1947 and 1965 infections caused by rotavirus (EDIM), mouse hepatitis virus, ectromelia, lymphocytic choriomeningitis virus and Citrobacter freundii were described and the pathogenesis explored by such investigators as Cheever and Mueller, Kraft, Jennings and Rumpf, Gledhill, Nelson, Marchal, Trentin and Briody, Mimms, Flynn, Hotchin, Brennan and their colleagues.
While data concerning disease-producing agents was being compiled quickly, others were making striking advances in the identification of murine viruses causing subclinical infection. Kilham isolated K-virus which was contaminating preparations of the Bittner agent in 1953. Smith, Hartley and Rowe each isolated and identified the mouse salivary gland virus. Rowe and Hartley discovered mouse adenovirus in 1960, as well as reovirus and thymic necrosis virus in 1961. Changes in a variety of physiological parameters were attributed to lactic dehydrogenase virus in 1960. Infection by polyomavirus was described by Gross, Stewart and Hartley during the 1950s. In 1963 Rowe published on the use of the Mouse-Antibody-Production (MAP) assay. In this paper he published on the distribution of 8 murine viruses in wild and colony mice and demonstrating a high prevalence of 4 viruses in mouse colonies in the US. In the mid 1960s, the British were preparing the first issue of Laboratory Animals and veterinarians and scientists throughout the world were calling for an end to rodents with intercurrent infections.
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The development of gnotobiotic and specific pathogen free colonies
Reproducing colonies of gnotobiotic mice have been maintained continuously since 1954 and were originally derived and hand reared at the Lobund Institute at the University of Notre Dame. Flexible-film isolators developed by Trexler in 1957 were a major advance allowing greater manoeuvrability and ease of maintenance (Trexler & Reynolds 1957) . Nelson used the technique of caesarean derivation and foster nursing to free rats of Mycoplasma pulmonis infection (Nelson 1957) and Rowe et al. demonstrated the absence of 6 clinically silent viruses in SPF and germfree rodents. Since germ-free (GF) rodents had an increased incidence of caecal enlargement and volvulus and a greater susceptibility to other infectious agents, attempts were made to associate the intestinal tract of GF rodents with a microflora. Gordon and Wostmann developed a technique in the 1950s based on feeding GF rats caecal contents from conventional rats. In 1965 Schaedler et al. developed a defined bacterial 'cocktail' which, to a large extent, eliminated intestinal volvulus but allowed microbial monitoring for pathogens to continue (Schaedler, Dubos & Costello 1965) . This 'cocktail' was later modified at the request of the National Cancer Institute to provide a microflora more typical of normal rodents which contained 8 bacterial strains varying in their oxygen sensitivity IOrcutt, Gianni & Judge 1987).
Diets for gnotobiotic rodents required fortification with heat-labile vitamins before sterilization, a practice which was commercially available by 1963. In June of 1962 the Institute of Laboratory Animal Resources, (National Academy of Sciences USA) sponsored the Third Symposium on Gnotobiotic Technology at the Lobund Institute with attendees from Canada, the UK and France. It was clear from the work presented on rodents, rabbits, dogs and swine that the technology was not far from commercial application (Hill 1963a) . The Laboratory Animal Handbook entitled: The Germ-free animal in Biomedical Research was and remains an indispensible text for those involved in gnotobiology (Coates & Gustafsson 1984) . In a 1980 article written by Henry Foster reflecting back on this period he states: 'the availability of gnotobiotes coupled with the major breakthrough and development of the flexible film plastic isolator by P. C. Trexler and the construction of the barrier facility for large-scale rearing of healthy animals, in my opinion was a quantum jump in the field of laboratory animal production' (Foster 1980) . It is noteworthy that the Association of Gnotobiotics is celebrating their 30th anniversary in 1992.
Laboratory animal housing and care in the US
The availability of Specific Pathogen Free (SPF) rodents associated with a defined flora was not sufficient to meet the needs of investigators. Facilities had to be constructed or renovated to provide a barrier against the introduction of infectious agents, housing had to be appropriate to meet the animals' needs and protect them from infection, and a system of monitoring had to be established and staffed with trained personnel. In the US these changes took place largely due to programmes established by the Division of Research Resources at the NIH [now known as the National Center for Research Resources) and through the efforts of the Institute for Laboratory Animal Resources (ILAR) at the National Academy of Sciences.
In 1962 ILAR was celebrating its tenth anniversary as a component of the Commission on Life Sciences at the National Academy of Sciences [USA). Its goals were to develop and make available scientific and technical information on laboratory animals and other biological resources to the federal government, the laboratory animal science and biomedical research communities and the public. On 16 November 1962, ILAR sponsored the first US symposium entirely devoted to housing of research animals which drew 163 over five hundred registrants to Washington, DC. The meeting served to build a communications bridge between biomedical and architectural disciplines. Papers were given on the criteria for animal room design; construction materialsj architectural, structural and mechanical systemsj isolation, quarantine and biocontainment facilities; considerations for dealing with hazardous agents; and environmental control including temperature, humidity, ventilation, noise and lighting. The proceedings of this meeting as well as a Guide for Laboratory Animal Facilities and Care (Animal Care Panel) were published in 1963 [Hill 1963b ). The Guide for Laboratory Animal Facilities and Care was adopted by the National Research Council and served as the basis for the Guide for the Care and Use of Laboratory Animals (Guide). The latter Guide has been revised 5 times under sponsorship of the National Institutes of Health (NIH) and 400000 copies have been distributed as English or Spanish editions (National Research Council 1985) . This Guide was written to provide sound advice on issues of facility design and management. Additional published documents contributing to our knowledge of facility design are the Laboratory Animal Handbook No. 7 entitled: Control of the Animal House Environment, Long Term Holding of Laboratory Rodents (National Research Council 1976) , and Laboratory Animal Housing (National Research Council 1978) .
As SPF animals became available and facilities were undergoing structural change, manufacturers of animal cages began meeting with laboratory animal specialists to discuss their needs. During the past 25 years dramatic changes have occurred in primary containment. Opentopped-shoebox-type cages were fitted with filter tops, and placed in horizontallaminar-flow units. Next to be developed were independently-ventilated cage units followed by the microisolator cage. The combination of microisolator caging and a class 2 biological safety cabinet changing unit has dramatically reduced the incidence of infectious disease even among immunodeficient rodents.
The role of the National Institutes of Health (USA) in developing laboratory animal programmes
The National Institutes of Health has been active in laboratory animal science activities dating back to 1958 with the establishment of the first lab animal veterinary training programme at the University of Michigan. Today the Laboratory Animal Science Program of the National Center for Research Resources (NCRR) supports 17 training grants and has provided support to train more than 250 laboratory animal specialists.
The NCRR sponsors the Comparative Medicine Program which provides support to seven Regional Primate Research Centers, to upgrade laboratory animal facilities, to provide diagnostic and laboratory services for research animal colonies, to train professional personnel, to identify and develop new and improved models and to breed certain scarce species. Among these programmes the Animal Diagnostic/ Investigative Laboratory Program was developed in the mid-1960s to protect NIH's investment in animal resources by funding diagnostic centres at universities throughout the US. The NIH has supported more than a dozen such centres which have made major contributions in the detection, control and prevention of animal diseases. The Diagnostic/Investigative Program has stimulated research leading to the development of improved diagnostic assays including the use of enzyme-linked immunoassay and molecular probes for identification of infectious agents. The laboratories have also served to focus the collective expertise in immunology, virology, microbiology, genetics and pathology on problems in comparative medicine and in doing so have aided in the identification of such new animal models of human disease as: ungulate models of lentivirus infections, non-human primate models of atherosclerosis and osteoporosis, the ferret model of peptic ulcer disease and Quimby gastric cancer, feline models of gangliosidosis, canine models of Lou Gehrig's disease (amyotrophic lateral sclerosis) and complement deficiency, a rabbit model of papillomatosis and rodent models of abnormal fatty acid metabolism, inherited torsion dystonia, Lyme disease, and the effects of insulin-like growth factors.
Another NCRR programme deals with development and improvement of institutional animal resources. This programme initiated in the early 1970s and reinvigorated in the 1980s made grants available on a matching basis to institutions seeking compliance with the Guide. In 1990 approximately 11 million dollars were made available.
Additional activities of the NCRR include support for the 7 regional primate centres active since 1960, the chimpanzee breeding and research colony programme established in 1986, the SPF rhesus monkey breeding and research programme established in 1988, and two reference centres involved with the collection and distribution of tissues and other biological specimens from laboratory, domestic and wild animals. The availability of federal funds to assist in the development of laboratory animal sciences nationwide helped take our profession to new heights in the US. During a time when the public interest in laboratory animals was increasing, the field had developed a professional presence. Veterinarians were being hired to operate institutional animal facilities, research was revealing the magnitude of certain problems and institutions with federal assistance were solving those problems. One additional element necessary in this rapidly evolving field was the organization of the lab animal science community and education.
World-wide organization of laboratory animal science
The first meeting of US laboratory animal scientists was held in Chicago on 28November 1950 and was attended by 75 individuals. Formal recognition of veterinary medical specialty fields by the American Veterinary Medical Association [AVMAIbegan in 1951. In 1957 laboratory animal medicine was accorded recognition when the American Board of Laboratory Animal Medicine was incorporated. In 1961 the organization changed its name to the American College of Laboratory Animal Medicine (ACLAM)and named diplomates to the specialty. ACLAM was established to encourage education, training and research in laboratory animal medicine, to establish standards of training and experience for qualification of specialists and to certify specialists by examination. Today ACLAMhas over 400 diplomates. The organization sponsors meetings in conjunction with theAVMAandAALASannually, organizes special scientific symposia, holds its own annual meeting, the ACLAM Forum, and publishes a series of textbooks on laboratory animal and comparative medicine.
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Additional US profeSSional organizations composed of veterinarians interested in laboratory animal medicine include the American Society of Laboratory Animal Practitioners (ASLAP),the Association of Primate Veterinarians (APVIand the American Committee on Laboratory Animal Diseases (ACLAD). Each of these organizations has their own educational programme and publication. Recently ACLAD made available reference antisera for viral, bacterial and mycoplasma species, for diagnosticians in Laboratory Animal Science. They also published a summary on Diagnostic Methods for Rodent Viral and Mycoplasmal Diseases (ACLAD 1991).
The Laboratory Animal Management Association was formed in 1984 to conduct management seminars and assist in training managers, increase the standards of those employed in the field, encourage appreciation for the role of managers, act as an advisory group, and provide a collective voice on management issues. They publish the LAMA Lines newsletter. The Allied Trade Association has operated continuously since 1968 and is open to any merchant, manufacturer, dealer or representative who purveys to the laboratory animal research industry. They are a chartered non-profit organization whose sole purpose is to ensure that the AALAS meetings will be mutually beneficial to all who attend. The role of industry in advancing the quality of laboratory animal care cannot be overstated. Finally, the American Association for the Accreditation of Laboratory Animal Care (AAALAC)was founded in 1965 by 14 charter organizations representing major professional groups in life sciences research and education. Since then, the number of member organizations has grown to 32. AAALACprovides a voluntary, peerreviewed accreditation process for animal care and use programmes. Today more than 540 programmes in the US are accredited. Accreditation is one step towards ensuring the public that animals used in research are treated humanely. In addition to those publications mentioned above, the Nature Publishing Company publishes the journal, Lab Animal which accepts papers on laboratory animal care and use. Outside the US similar organizations were formed.
In Canada the Canadian Association of Laboratory Animal Medicine was founded in 1981 and currently is composed of 65 member veterinarians. Their objectives are to promote ethics and professionalism in the field of laboratory animal medicine, to act as a voice on special issues, disseminate knowledge, generate information and promote interaction with the laboratory animal community. CALAM sponsors seminars, compiles Standard Operating Procedures, and is currently producing a textbook. The Canadian Association for Laboratory Animal Science (CALAS)was founded in 1962 as the Canadian Society for Animal Care. It is dedicated to the elimination of both inhumane and unnecessary use of animals in research and the improvement of their standard of care. Membership includes both professionals and technicians who strive to advance knowledge on the proper care of animals and improve standards for animal care. CALASpublishes a newsletter and hosts an annual convention. The organization has regional chapters, provides a Registry of Laboratory Animal Technicians and awards excellence in the field.
World-wide societies have been organized to promote education and elevate standards for laboratory animal care. At least 11 societies exist in Western Europe alone and noteworthy among them is the Laboratory Animal Science Association of the UK, the Society of Laboratory Animal Science in Germany and the Dutch Association of Laboratory Animal Science, which have Laboratory Animals as their associations' journal. Laboratory Animals Ltd in addition to producing the journal, Laboratory Animals, has a history of producing fine texts covering numerous aspects of laboratory animal care and management called the Laboratory Animal Handbook series. In addition to those titles already mentioned, the Handbooks cover: the design and function of laboratory animal houses, dietary standards for laboratory rats and mice, transplantable tumours, hazards Quimby associated with simians, safety in the animal house, breeding simians for developmental biology, technical procedures in reproductive toxicology, parasites in laboratory animals and the International Index of Laboratory Animals (now in its fifth edition). Laboratory Animals Ltd has also begun to award training scholarships. The Institute of Animal Technology, a leading UK organization for training animal technicians, also publishes the journal Animal Technology which contains articles of relevance to laboratory animal science submitted by authors from around the world. The Universities Federation for Animal Welfare (UFAW) was founded by the late Major C. W. Hume in 1926 as the University of London Animal Welfare Society. It changed its name to the UFAW in 1938 and expanded its membership. This organization is committed to the welfare and humane treatment of animals, both wild and domestic, in the UK and abroad. The organization has published Guidelines on the care of laboratory animals, standards in laboratory animal management as well as numerous publications dealing with food, companion, zoo and wild animals. In addition, the organization published the UFAW Courier, an occasional series dedicated to issues on animal welfare, and the Hume Memorial Lecturers. But the one volume most closely identified by laboratory animal veterinarians with the UFAW is the Handbook on The Care and Management of Laboratory Animals now in its sixth edition (Poole 1987) . In 1967 when I registered for my first course in laboratory animal medicine, this was one of the few, and definitely the most comprehensive documents on laboratory animal care. I have lived and learned from four editions of the Handbook and continue to keep it close at hand as a reference text.
Other European laboratory animal societies with journals on laboratory animal medicine and care include the French Society which publishes STAL, and the Scandinavian Federation of Laboratory Animal Science publishing the Scandinavian Journal of Laboratory Animal Science. In addition, the international journal, Journal of Experimental Animal Science publishes articles in English and German. These are but a few of the European organizations whose members have interest in laboratory animals.
The Federation of European Laboratory Animal Science Associations IFELASA)was formed in 1978 to serve as a focal point for exchange of information on laboratory animal science among European nations. Its membership is restricted to nations of the European Economic Community and the Council of Europe. It holds scientific meetings every third year and in addition has established 3 working groups to deal with education, animal health and the assessment and alleviation of pain in animals.
Many other societies continue to play an important role in Asia, Africa, New Zealand and Australia. The journal entitled Experimental Animals is the official publication of the Japanese Association of Laboratory Animal Science. In addition nations throughout the world are members of the International Council of Laboratory Animal Science IICLAS).
ICLAS was established in 1956 at the initiative of the United Nations Educational, Scientific and Cultural Organizations (UNESCO), the Council for International Organizations of Medical Sciences, and the International Union of Biological Sciences. It is a non-governmental organization for international cooperation in laboratory animal science. Its membership includes 40 countries world-wide. ICLAS sponsors meetings every four years, the last being held in Buffalo, NY in 1991 where many exciting symposia were given. ICLAS also provides training scholarships and student travel fellowships. of Reference and Monitoring Centers located world-wide. The important role of ICLAS and WHO-sponsored reference centres throughout the world cannot be overemphasized. We have thus seen major advances in husbandry, genetics, microbial quality assurance and education. Together these factors have contributed to improved animal health and lessen variability in research. However, our activities, as a profession, are not complete and additional attention must be given to such topics as education, safety, conservation and genetics in the future.
The future of laboratory animal science
Education
There are still many countries of the world with no organized societies or programmes in laboratory animal science. In fact, the entire continent of South America is without a programme. The World Veterinary Association (WVAI held a major symposium in Rio de Janeiro, Brazil in 1991, it was well attended by veterinarians from throughout South America (Seamer & Quimby 1992) . The registrants asked for desperately needed educational materials to instruct veterinary students in animal welfare and laboratory animal medicine. One future challenge for ICLAS, perhaps together with such groups as the Committee on Animal Welfare of the WVA is to assist South American institutions with standardization and improved conditions for laboratory (and all other) animals.
The next few years will be critical for the professional organizations of EC countries as they implement research animal legislation. A lion's share of the responsibility in this coordination will fall on FELASA which will need everyone's support. With rising costs and world-wide recession we must all make an extra effort to cooperate, share resources and encourage governmental support for laboratory animal science so that precious national resources remain available to our community.
Safety
Safety will continue to be a major concern. Despite current programmes to breed Bvirus free rhesus monkeys, develop equipment for the safe disposal of bedding and housing of infected animals, as well as special procedures for handling infectious specimens e.g. class II animal surgery tables much remains to be achieved. Recen~ly the Centers for Disease Control (CDC) in the US described 2 laboratory workers apparently infected with Simian Immunodeficiency Virus (SIV) (Centers for Disease Control 1992). A new programme has been established at the CDC to monitor those who work with SIV or SIVinfected monkeys. In addition, Herpes virus simiae (B-virus) continues to pose a threat to laboratory workers. Excellent articles recently published by Lees et ai. from the Central Public Health Laboratory, and the Centre for Applied Microbiology and Research here in the UK warn us of the importance of this agent (Lees et al. 1991) . The US was also plagued by the introduction of a filovirus which serologically cross-reacted with Ebola virus and was found to cause fatal illness in cynomolgus monkeys. Although monkey handlers seroconverted, no clinical disease has been observed (Centers for Disease Control 1990). This disease also continues to be monitored. In all cases, basic research coupled with employee education appear to be the best strategy for dealing with newly emerging infections. Transgenic mice, made susceptible to HIV infection, present new challenges in biocontainment.
Conservation
Many animal species continue to be driven to the point of endangerment throughout the world. Unfortunately some, such as the chimpanzee, provide the best models for certain human diseases. We should take maximum advantage of the new technology available in the creation of transgenic rodents or scid/hu mice which may reduce the numbers of this and other threatened and endangered species used. The recent announcement by the Food and Drug Quimby Administration (USA) that the US, European countries and Japan will work together to harmonize animal testing regulations thus reducing the number of animals needed by eliminating duplication is a step in the right direction (Food and Drug Administration 1992) .
Transgenic mice and other valuable models of inherited human disease offer us future challenges in humane animal care. Animals with muscular dystrophy, sudden infant death syndrome, cystic fibrosis, and thyroiditis require special housing, diets, therapy and monitoring and transgenic animals pose new challenges for genetic quality assurance.
Genetics
New information has been presented about mouse genetics, murine models of disease, mouse chromosome mapping and syntery homologies between mouse and man and the exponential growth in the discovery of new murine loci. Discoveries made in the fruit fly and mouse have lead to important contributions in human genetics. The current human genome project has also sparked interest in a canine genome project currently involving five institutions in the US. The benefits of this research are already apparent as animal models of human disease, involving the same defective gene, are being used to evaluate the efficacy of somatic cell gene therapy. In addition, our ability to produce new genetic models in animals is likely to further the progress of treatment for inherited diseases such as cystic fibrosis [Clarke et al. 1992) ; however, we must be constantly mindful of the ethical costs of these studies. Another future challenge will be to ensure that the genetic constitution of these animals is preserved during breeding and experimental use.
While information concerning the genetics of mice has arisen from a truly international effort, it would be remiss not to mention the contributions of the Jackson Laboratory. The laboratory celebrated its 50th anniversary in 1979. Its originator, Dr C. C. Little, had 3 interests-the mouse, genetics and cancer research. Dr Little diligently bred many of the strains commonly used today and identified many of the early mutations. He was interested in tumours and postulated the genetic basis of tumour rejection. This work was carried to new heights by George Snell who helped discover the major histocompatibility complex. For his contributions Dr Snell was a co-recipient of the Nobel Prize in Medicine and Physiology in 1980. Many of you know the Jackson Laboratory suffered an enormous fire in 1989. The good news is that, thanks to a $9 million grant from the Nlli, a new set of buildings have been constructed which will ensure the availability of mutant strains of mice for the entire biomedical research community.
Laboratory animal diseases
Continued research in laboratory animal diseases and control of pain in animals is still critically needed. New diseases are constantly emerging and preventions must be sought. Research Council 1991) . To keep a motivated, well trained faculty, like the Yale group, functioning as a unit, continued financial support from the federal government and private industry are necessary. Maintaining such support during a recession is imperative, if advances in laboratory animal science are to continue. Enhanced education, and continued progress in the areas of safety, conservation, genetics, special veterinary care and cost 169 containment are but some of the concerns the future holds. The prospects for future discoveries using animals are bright. In 1984 the WHO published a list of the most prevalent human diseases for which new treatments or preventions must be developed. This list included malaria, leishmaniasis, filariasis, trypanosomiasis (Paton 1984) . Since then public health officials have warned us of increasing drugresistance among species of malaria (Marshall 19911 . Recently the WHO announced it will commence clinical trials on 3 new compounds to combat drugresistant malaria (Hamilton 1991) . This followed a recent announcement of the first vaccine shown to protect non-human primates from challenge with malaria (Etlinger et al. 1991) . Based in part on animal studies, a liposomal malaria vaccine has been demonstrated to be safe and potent in humans (Fries et al. 1992) . Hopefully human clinical trials to demonstrate vaccine efficacy will begin soon. Human clinical trials involving new vaccines to protect against HIV infection have just been announced [Cohen 1991} based on protection of monkeys and chimpanzees in numerous laboratories throughout the US and Europe (Fultz et al. 1992 ). I began this paper by stating that 54 of the first 76 Nobel Prizes in Medicine and Physiology (ending in the year 1982) were awarded to individuals who used animals to make their discoveries. Each of the Nobel Prizes awarded between 1983-1991 also depended, in part, on animal use. Clearly animal-based research will be necessary for medical advances in the future.
Finally, we must remain mindful of the words of Russell and Burch to reduce, refine and replace animals whenever possible [Russell & Burch 1959} . Despite previous successes leading to improved care as well as reduced animal numbers, the need for research involving animals will remain. With this in mind, I will close with a quote from Major C. W. Hume who brought us a message as important today as it was in 1976, 'It fortunately happens that the animals most suitable for scientific research are those that are healthy, tame, comfortable and contented and that wastefulness or irresponsibility in dealing with them is as discreditable on scientific as on humanitarian grounds' (Poole 1987) .
